AstraZeneca Cancer Drug Review Delayed
AstraZeneca's breast cancer treatment application faces extended review by FDA, potentially impacting approval timeline. This may affect AstraZeneca's stock performance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.